Literature DB >> 25947348

Pulmonary embolism response teams.

Nosheen Reza1, David M Dudzinski.   

Abstract

OPINION STATEMENT: Pulmonary embolism (PE) is a complex and multidimensional pathophysiology, the diagnosis and management of which spans multiple disciplines. The high morbidity and associated mortality of "massive" and "submassive" acute PE may require prompt, definitive management; however, current consensus guidelines in this domain are not supported by high-level evidence. Randomized clinical trials comparing available pharmacologic and invasive treatment modalities-including anticoagulation, thrombolysis, and embolectomy-have not been conducted and continue to be challenging to conceptualize, design, and execute. Consequently, time-sensitive therapeutic determinations are largely not standardized, and rendered on a case-by-case basis in part depending on institutional practices and expertises. Chronic sequelae of PE, such as chronic thromboembolic pulmonary hypertension and right heart failure, are increasingly identified as conditions necessitating longitudinal specialty care. These and other challenges have created a niche for a multidisciplinary team which can respond rapidly to unstable patient scenarios, appropriately deploy resources, and offer highly specialized acute and chronic management of PE. The Massachusetts General Hospital Pulmonary Embolism Response Team (PERT), modeled after existing rapid response and collaborative care teams, is a novel approach that combines this clinical service with the development of an educational and research framework to advance the care of patients with PE.

Entities:  

Year:  2015        PMID: 25947348     DOI: 10.1007/s11936-015-0387-9

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  30 in total

1.  Long-term clinical outcome in the Bypass Angioplasty Revascularization Investigation Registry: comparison with the randomized trial. BARI Investigators.

Authors:  F Feit; M M Brooks; G Sopko; N M Keller; A Rosen; R Krone; P B Berger; R Shemin; M J Attubato; D O Williams; R Frye; K M Detre
Journal:  Circulation       Date:  2000-06-20       Impact factor: 29.690

2.  Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial.

Authors:  D W BARRITT; S C JORDAN
Journal:  Lancet       Date:  1960-06-18       Impact factor: 79.321

3.  2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  L David Hillis; Peter K Smith; Jeffrey L Anderson; John A Bittl; Charles R Bridges; John G Byrne; Joaquin E Cigarroa; Verdi J Disesa; Loren F Hiratzka; Adolph M Hutter; Michael E Jessen; Ellen C Keeley; Stephen J Lahey; Richard A Lange; Martin J London; Michael J Mack; Manesh R Patel; John D Puskas; Joseph F Sabik; Ola Selnes; David M Shahian; Jeffrey C Trost; Michael D Winniford
Journal:  Circulation       Date:  2011-11-07       Impact factor: 29.690

4.  The 100,000 lives campaign: setting a goal and a deadline for improving health care quality.

Authors:  Donald M Berwick; David R Calkins; C Joseph McCannon; Andrew D Hackbarth
Journal:  JAMA       Date:  2006-01-18       Impact factor: 56.272

5.  A multidisciplinary pulmonary embolism response team.

Authors:  Christopher Kabrhel; Michael R Jaff; Richard N Channick; Joshua N Baker; Kenneth Rosenfield
Journal:  Chest       Date:  2013-11       Impact factor: 9.410

6.  The Massachusetts General Hospital Pulmonary Embolism Response Team (MGH PERT): creation of a multidisciplinary program to improve care of patients with massive and submassive pulmonary embolism.

Authors:  Tim Provias; David M Dudzinski; Michael R Jaff; Kenneth Rosenfield; Richard Channick; Joshua Baker; Ido Weinberg; Cameron Donaldson; Rajeev Narayan; Andrew N Rassi; Christopher Kabrhel
Journal:  Hosp Pract (1995)       Date:  2014-02

7.  Cardiopulmonary arrest and mortality trends, and their association with rapid response system expansion.

Authors:  Jack Chen; Lixin Ou; Kenneth M Hillman; Arthas Flabouris; Rinaldo Bellomo; Stephanie J Hollis; Hassan Assareh
Journal:  Med J Aust       Date:  2014-08-04       Impact factor: 7.738

8.  Inpatient resource use and cost burden of deep vein thrombosis and pulmonary embolism in the United States.

Authors:  Joyce C LaMori; Omar Shoheiber; Samir H Mody; Brahim K Bookhart
Journal:  Clin Ther       Date:  2014-12-15       Impact factor: 3.393

9.  Derivation and validation of a prognostic model for pulmonary embolism.

Authors:  Drahomir Aujesky; D Scott Obrosky; Roslyn A Stone; Thomas E Auble; Arnaud Perrier; Jacques Cornuz; Pierre-Marie Roy; Michael J Fine
Journal:  Am J Respir Crit Care Med       Date:  2005-07-14       Impact factor: 21.405

10.  An official American Thoracic Society/American College of Chest Physicians policy statement: the Choosing Wisely top five list in adult pulmonary medicine.

Authors:  Renda Soylemez Wiener; Daniel R Ouellette; Edward Diamond; Vincent S Fan; Janet R Maurer; Richard A Mularski; Jay I Peters; Scott D Halpern
Journal:  Chest       Date:  2014-06       Impact factor: 9.410

View more
  6 in total

Review 1.  Acute pulmonary embolism: endovascular therapy.

Authors:  Stephen P Reis; Ken Zhao; Noor Ahmad; Reginald S Widemon; Christopher W Root; Seth M Toomay; James M Horowitz; Akhilesh K Sista
Journal:  Cardiovasc Diagn Ther       Date:  2018-06

Review 2.  Catheter-directed interventions for pulmonary embolism.

Authors:  Mehrzad Zarghouni; Hearns W Charles; Thomas S Maldonado; Amy R Deipolyi
Journal:  Cardiovasc Diagn Ther       Date:  2016-12

Review 3.  Multidisciplinary approach to the management of pulmonary embolism patients: the pulmonary embolism response team (PERT).

Authors:  Christopher W Root; David M Dudzinski; Bishoy Zakhary; Oren A Friedman; Akhilesh K Sista; James M Horowitz
Journal:  J Multidiscip Healthc       Date:  2018-04-05

Review 4.  COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review.

Authors:  Behnood Bikdeli; Mahesh V Madhavan; David Jimenez; Taylor Chuich; Isaac Dreyfus; Elissa Driggin; Caroline Der Nigoghossian; Walter Ageno; Mohammad Madjid; Yutao Guo; Liang V Tang; Yu Hu; Jay Giri; Mary Cushman; Isabelle Quéré; Evangelos P Dimakakos; C Michael Gibson; Giuseppe Lippi; Emmanuel J Favaloro; Jawed Fareed; Joseph A Caprini; Alfonso J Tafur; John R Burton; Dominic P Francese; Elizabeth Y Wang; Anna Falanga; Claire McLintock; Beverley J Hunt; Alex C Spyropoulos; Geoffrey D Barnes; John W Eikelboom; Ido Weinberg; Sam Schulman; Marc Carrier; Gregory Piazza; Joshua A Beckman; P Gabriel Steg; Gregg W Stone; Stephan Rosenkranz; Samuel Z Goldhaber; Sahil A Parikh; Manuel Monreal; Harlan M Krumholz; Stavros V Konstantinides; Jeffrey I Weitz; Gregory Y H Lip
Journal:  J Am Coll Cardiol       Date:  2020-04-17       Impact factor: 24.094

5.  Effects of a Consensus-Based Pulmonary Embolism Treatment Algorithm and Response Team on Treatment Modality Choices, Outcomes, and Complications.

Authors:  Roman Melamed; Catherine A St Hill; Bjorn I Engstrom; David M Tierney; Claire S Smith; Vincent K Agboto; Brynn E Weise; Peter M Eckman; Nedaa Skeik
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

6.  Role of Pulmonary Embolism Response Team in patients with intermediate- and high-risk pulmonary embolism: a concise review and preliminary experience from China.

Authors:  Ying Liang; Shao-Ping Nie; Xiao Wang; Ashley Thomas; Elizabeth Thompson; Guan-Qi Zhao; Jing Han; Jing Wang; Mark J D Griffiths
Journal:  J Geriatr Cardiol       Date:  2020-08       Impact factor: 3.327

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.